# AltrixBio, Inc. — Form D

AltrixBio, Inc. of Lowell, MA, a company, filed a Form D exempt-offering notice with the SEC on 2025-06-13. The offering totals $10.0M, of which $1.2M was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2025-06-13
- Form: D
- Accession: 0001080368-25-000012
- Industry: Pharmaceuticals
- Exemptions: 04, 06c, 4a5
- Total offering: $10.0M
- Amount sold: $1.2M
- Remaining: $8.8M
- Minimum investment: $10K
- Investors: 20
- Date of first sale: 2019-03-18
- Revenue range: Decline to Disclose
- SEC file number: 021-548969

## Issuer

- Name: AltrixBio, Inc.
- CIK: 0002040517
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 110 Canal Street, Lowell, MA, 01852
- Phone: 302-658-7581

## Officers, directors & promoters (5)

| Name | Role | Location |
| --- | --- | --- |
| Nancy Briefs | Director | London, X0 |
| Nancy Briefs | Executive Officer | London, X0 |
| John Brooks | Director | Mississauga, A6 |
| Jeffrey Karp | Director | Lowell, MA |
| Ali Tavakkoli | Director | Lowell, MA |

## Other filings by this issuer (2)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2025-06-16](https://search.stillhousedata.com/formd/0001080368-25-000014) | D | $10.0M | $1.2M |
| [2025-06-13](https://search.stillhousedata.com/formd/0001080368-25-000013) | D/A | $6.6M | $6.6M |

## More

- [CIK 2040517 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2040517&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001080368-25-000012.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.